HIGHFDA DEVICE

Roche Diagnostics Recalling Anti-TSHR Immunoassay Over Diagnosis Risk

Roche Diagnostics Operations recalled 1,300 Anti-TSHR immunoassay cassettes on November 21, 2025. Variability in results may lead to incorrect diagnoses and treatment delays. The recall affects multiple states across the U.S.

Official notice
Roche Diagnostics OperationsHealth & Personal CareMedical Devices08496633190 lot 840183 exp. 02/2608496633190 lot 874011 exp. 10/2608496609190 lot 840177 exp. 05/26

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
November 21, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
November 21, 2025
Hazard Level
HIGH
Brand
Roche Diagnostics Operations
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Roche Diagnostics Operations
Product type
Immunoassay
Model numbers
08496633190 lot 840183 exp. 02/26, 08496633190 lot 874011 exp. 10/26, 08496609190 lot 840177 exp. 05/26
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    November 21, 2025

  2. Reported by FDA DEVICE

    January 14, 2026

  3. RecallRadar source check

    January 21, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Roche Diagnostics Operations, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

The Elecsys Anti-TSHR immunoassay is a diagnostic test used to measure antibodies related to thyroid function. Healthcare providers utilize this test to aid in diagnosing thyroid disorders.

Why This Is Dangerous

Variability in test results based on the instrument platform used can lead to misinterpretation of patient health. This may result in delayed or incorrect treatment for thyroid-related conditions.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may experience delays in diagnosis and treatment, leading to potential worsening of thyroid disorders if the test results are inaccurate.

Practical Guidance

How to identify if yours is affected

  1. Check the model numbers and lot numbers against the recall list.
  2. Verify the expiration dates of your immunoassay cassettes.
  3. Contact your healthcare provider for assistance in identifying affected products.

Where to find product info

Serial numbers and lot numbers are typically printed on the product packaging or the product itself.

What timeline to expect

Expect processing for refunds to take 4-6 weeks after the return is received by Roche Diagnostics.

If the manufacturer is unresponsive

  • Document all correspondence with Roche Diagnostics.
  • Follow up via phone or email if you do not receive a timely response.
  • Consider reporting unresolved issues to the FDA.

How to prevent similar issues

  • Always verify that medical devices have current certifications and reviews.
  • Look for recent warnings or recalls on medical devices before purchase.
  • Consult healthcare providers for recommendations on reliable diagnostic tests.

Documentation advice

Keep records of your purchase, correspondence regarding the recall, and any medical advice received.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves the Elecsys Anti-TSHR immunoassay with model numbers 08496633190 lot 840183 exp. 02/26, 08496633190 lot 874011 exp. 10/26, and 08496609190 lot 840177 exp. 05/26. The product was distributed nationwide in states including California, Texas, and Florida.

Key Facts

  • Class II recall
  • Potential for misdiagnosis
  • Nationwide distribution in the U.S.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
08496633190 lot 840183 exp. 02/26
08496633190 lot 874011 exp. 10/26
08496609190 lot 840177 exp. 05/26
Affected States
ALL
Report Date
January 14, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more